ACCLARENT AERA EUSTACHIAN TUBE BALLOON DILATION SYSTEM: payments to doctors
Payments that named ACCLARENT AERA EUSTACHIAN TUBE BALLOON DILATION SYSTEM as the associated device or medical supply, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $156K
- Providers
- 939
- Transactions
- 1,559
- Average per transaction
- $100
The per-transaction average — $100 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 939 providers the average total is $166, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Acclarent, Inc | $155,324 | 99.6% |
| Medical Device Business Services, Inc. | $447 | 0.3% |
| Biosense Webster, Inc. | $143 | 0.1% |